Abstract |
Induction of ovulation with subcutaneous pulsatile (every 90 min.) administration of HMG ( Pergonal) 75 or 150 IU/day using a portable pump (Nipro SP-3I) was performed in 3 PCO patients (6 cycles), 4 first grade amenorrhea (Am-I) patients (7 cycles) and 4 Am-II patients (4 cycles). All patients ovulated except one cycle of Am-I patients and one PCO woman conceived. In regard to the duration of administration and the total dose of HMG until ovulation, the administration of 150 IU/day (M +/- SD=15.2 +/- 5.0 days, 2280 +/- 774 IU) is superior to 75 IU/day (39.5 +/- 11.4 days, 3900 +/- 1357 IU), and there was no significant difference between this method and the daily intramuscular injection of HMG. The group treated with HCG in the luteal phase revealed a longer luteal phase (14.0 +/- 2.3 days) than the nontreated group (12.6 +/- 1.5 days). Ovarian hyperstimulation was observed in one case and subsided spontaneously after admission. There were no other side effects. In conclusion, this method has the following advantages: A high ovulation rate, comparable with daily intramuscular administration. It is a less painful procedure than daily intramuscular injection. It is possible for the patient to lead normal life, insertion and removal being easily done by herself.
|
Authors | Y Nakamura, S Kido, Y Kowaguchi, Y Tamaoka, S Hara, Y Higuchi, S Shiraishi, Y Yoshimura, R Iizuka, T Oda |
Journal | Nihon Sanka Fujinka Gakkai zasshi
(Nihon Sanka Fujinka Gakkai Zasshi)
Vol. 37
Issue 7
Pg. 1169-76
(Jul 1985)
ISSN: 0300-9165 [Print] Japan |
PMID | 3928777
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Amenorrhea
(drug therapy)
- Drug Administration Schedule
- Female
- Humans
- Menotropins
(administration & dosage)
- Ovulation
(drug effects)
- Ovulation Induction
- Pregnancy
|